medigraphic.com
ISSN 2448-5640 (Print)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2023, Number 4

<< Back Next >>

Cir Card Mex 2023; 8 (4)

Transcatheter mitral valve intervention as a bridge to transplant: A fructibus cognosictur arbor

Orozco-Hernández EJ

Language: English
References: 8
Page: 94-95
PDF size: 167.93 Kb.


Text Extraction

Approximately 3000 heart transplants (HTs) are performed in the United States each year. Overall 1-, 3-, and 5-year survival for adult patients who underwent HT in 2010–2012 was 90.5%, 84.1%, and 79.1%, respectively. However, mortality of those awaiting an HT remains high, as high as 11 deaths per 100 waitlist years. In an effort to optimize the utilization of scarce donor hearts, the United Network for Organ Sharing (UNOS) revised the heart allocation policy in the United States, and has accorded patients on non-dischargeable MCS, including ECMO, the highest priority for cardiac transplant on the waitlist as of October 18, 2018.
I read with interest the manuscript by Godino et al. on MitraClip in patients who are (potential) candidates for heart transplantation. The MitraBridge is the first international, multicenter (17 centers) registry reporting data on 119 consecutive advanced HF patients with significant secondary mitral regurgitation treated with MitraClip as a bridge-to-transplant (BTT) strategy.


REFERENCES

  1. Colvin M, Smith JM, Hadley N, et al. OPTN/SRTR 2018 Annual Data Report:heart. Am J Transplant. 2020;20(s1):340-426. doi:10.1111/ajt.15676.

  2. Orozco-Hernandez E, DeLay TK, Gongora E, et al. State of the art – Extracorporealmembrane oxygenation as a bridge to thoracic transplantation. Clin Transplant.2022;e14875. https://doi.org/10.1111/ctr.14875.

  3. Godino C, Munafò A, Scotti A, et al. MitraClip in secondary mitral regurgitationas a bridge to heart transplantation: 1-year outcomes from the InternationalMitraBridge registry. J Heart Lung Transplant 2020;39:1353-62. doi: 10.1016/j.healun.2020.09.005.

  4. Garcia-Villarreal OA. Ringless MitraClip therapy: is it time to learn to give up?Eur J Cardiothorac Surg 2013; 44:193. doi:10.1093/ejcts/ezs716.

  5. Mehra MR, Costanzo MR. Transcatheter mitral valve intervention in advancedheart failure. J Heart Lung Transplant. 2020;39(12):1363-1365. doi: 10.1016/j.healun.2020.09.004.

  6. Langer F, Schäfers HJ. RING plus STRING: papillary muscle repositioning as anadjunctive repair technique for ischemic mitral regurgitation. J Thorac CardiovascSurg. 2007;133(1):247-9. doi: 10.1016/j.jtcvs.2006.04.059.

  7. Kanwar MK, Rajagopal K, Itoh A, et al. Impact of left ventricular assist deviceimplantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial.J Heart Lung Transplant. 2020;39(6):529-537. doi: 10.1016/j.healun.2020.03.003.

  8. Pappalardo F, Morici N, Colombo P. MitraBridge and left ventricular assist device:Crossing dangerous bridges. J Heart Lung Transplant . 2021 ;40(4):316-317.doi: 10.1016/j.healun.2021.01.004.




2020     |     www.medigraphic.com